INIS
diseases
100%
patients
100%
modulation
100%
cell cultures
100%
plasma
100%
permeability
100%
barriers
45%
tumor necrosis factor
45%
control
27%
cysts
18%
incubation
18%
data
9%
levels
9%
comparative evaluations
9%
phosphorylation
9%
concentration
9%
messenger-rna
9%
proteins
9%
monoclonal antibodies
9%
Keyphrases
Intestinal Permeability
100%
Crohn's Disease
100%
Three-dimensional Cell Culture Models
100%
Tumor Necrosis Factor-α
50%
Healthy Controls
37%
Disease Activity
25%
Cyst
25%
Barrier Dysfunction
25%
Adalimumab
25%
Pre-incubation
25%
SP600125
25%
Protein Level
12%
MRNA Level
12%
Activity-dependent
12%
Patient-controlled
12%
Plasma Concentration
12%
Intestinal Barrier Function
12%
Mitogen-activated Protein Kinase
12%
Plasma Samples
12%
Epithelial Barrier Dysfunction
12%
Intestinal Epithelial Barrier
12%
Monoclonal Antibody
12%
Patient Plasma
12%
Paracellular Permeability
12%
Zonula occludens-1 (ZO-1)
12%
Caco-2
12%
Active Crohn's Disease
12%
Plasma-induced
12%
JNK Isoforms
12%
JNK Phosphorylation
12%
Tumour Necrosis Factor Inhibitor (TNFi)
12%
Immunology and Microbiology
Blood Plasma
100%
Cell Culture
100%
Crohn's Disease
100%
Tumor Necrosis Factor Alpha
55%
Adalimumab
22%
Blood Level
11%
Monoclonal Antibody
11%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Cell Culture
100%
Tumor Necrosis Factor
44%
Disease Activity
22%
Adalimumab
22%
anthra[1,9 Cd]pyrazol 6(2h) One
22%
Monoclonal Antibody
11%
Tumor Necrosis Factor Inhibitor
11%
Stress Activated Protein Kinase Inhibitor
11%
Messenger RNA
11%